Dopamine and antipsychotics. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy21

Corpus Striatum Nucleus Accumbens Neostriatum Brain Dopaminergic Neurons Caudate Nucleus Substantia Nigra Ventral Tegmental Area Neurons Mesencephalon Prefrontal Cortex Basal Ganglia Putamen Medial Forebrain Bundle Limbic System Synaptosomes Extracellular Space Tegmentum Mesencephali Cerebral Cortex Hippocampus Neural Pathways

Organisms2

Rats, Sprague-Dawley Rats, Wistar

Diseases21

Basal Ganglia Diseases Dyskinesia, Drug-Induced Catalepsy Akathisia, Drug-Induced Psychomotor Agitation Hyperprolactinemia Weight Gain Galactorrhea Hyperkinesis Neuroleptic Malignant Syndrome Dementia Movement Disorders Parkinsonian Disorders Delirium Parkinson Disease, Secondary Metabolic Diseases Disease Models, Animal Cocaine-Related Disorders MPTP Poisoning Psychomotor Disorders Laryngeal Diseases

Chemicals and Drugs129

Dopamine Antipsychotic Agents Receptors, Dopamine D2 Dopamine Antagonists Risperidone Receptors, Dopamine D1 Dopamine Agonists Clozapine Receptors, Dopamine Receptors, Dopamine D3 Haloperidol Dibenzothiazepines Benzodiazepines Dopamine Plasma Membrane Transport Proteins Dopamine Agents Sulpiride Receptors, Dopamine D5 Dopamine Uptake Inhibitors Dopamine beta-Hydroxylase Apomorphine Psychotropic Drugs Benzazepines Fluphenazine Perphenazine Raclopride Pirenzepine Quinpirole Piperazines Amphetamine Receptor, Serotonin, 5-HT2A Chlorpromazine Phenothiazines Flupenthixol Pimozide Salicylamides Cocaine Levodopa Homovanillic Acid Thioridazine Remoxipride Antidepressive Agents Tyrosine 3-Monooxygenase Quinolones Dopamine and cAMP-Regulated Phosphoprotein 32 Spiperone Thiazoles Phencyclidine Serotonin Antagonists Oxidopamine Ergolines Perazine Receptors, Serotonin Central Nervous System Stimulants Antimanic Agents Serotonin Antiparkinson Agents Lithium Carbonate Biperiden Loxapine Clopenthixol alpha-Methyltyrosine Domperidone Prolactin Dihydroxyphenylalanine Receptors, Serotonin, 5-HT2 Nomifensine Isoxazoles Catechol O-Methyltransferase Tropanes Bromocriptine Vesicular Monoamine Transport Proteins Serotonin Uptake Inhibitors Central Nervous System Agents Cholinergic Antagonists Tranquilizing Agents Delayed-Action Preparations Neurotensin Methamphetamine Biogenic Monoamines Butaclamol Isoindoles Piperidines Anti-Anxiety Agents Penfluridol Benzoxazoles Fluspirilene Dibenzothiepins Receptors, Dopamine D4 Norepinephrine Serotonin Receptor Agonists Catecholamines Reserpine Serotonin 5-HT2 Receptor Antagonists 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Pergolide Dizocilpine Maleate Nerve Tissue Proteins Dextroamphetamine Carbidopa Anticonvulsants Excitatory Amino Acid Antagonists Hydroxydopamines Antidepressive Agents, Tricyclic Benztropine Aromatic-L-Amino-Acid Decarboxylases Placebos Receptors, N-Methyl-D-Aspartate Indoles Octopamine Pyrrolidines Tyramine Benzamides Methylphenidate Drugs, Generic Tetrahydronaphthalenes Biogenic Amines Lithium Compounds Monoamine Oxidase Neurotransmitter Agents Adrenergic Agents Triazines Neuronal Calcium-Sensor Proteins Dopa Decarboxylase Mazindol Hydroxyindoleacetic Acid Lisuride Tetrabenazine Vesicular Biogenic Amine Transport Proteins Norepinephrine Plasma Membrane Transport Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment32

Off-Label Use Polypharmacy Microdialysis Startle Reaction Drug Substitution Pharmacovigilance Treatment Outcome Analysis of Variance Delayed-Action Preparations Drug Therapy, Combination Drug Prescriptions Radioligand Assay Randomized Controlled Trials as Topic Positron-Emission Tomography Drug Administration Schedule Long-Term Care Double-Blind Method Autoradiography Self Administration Disease Models, Animal Placebos Risk Factors Retrospective Studies Electrochemical Techniques Clinical Trials as Topic Hospitalization Individualized Medicine Injections, Intramuscular Electric Stimulation Cross-Sectional Studies Adverse Drug Reaction Reporting Systems Drug Monitoring

Psychiatry and Psychology29

Schizophrenia Psychotic Disorders Schizophrenic Psychology Schizophrenia, Paranoid Psychomotor Agitation Startle Reaction Behavior, Animal Bipolar Disorder Brief Psychiatric Rating Scale Psychiatric Status Rating Scales Motor Activity Mental Disorders Stereotyped Behavior Reward Dementia Psychiatry Mood Disorders Delirium Medication Adherence Cognition Disorders Avoidance Learning Conditioning, Operant Cocaine-Related Disorders Attention Deficit Disorder with Hyperactivity Aggression Psychomotor Disorders Reinforcement (Psychology)Neuropsychological Tests Cognition

Phenomena and Processes9

Startle Reaction Dose-Response Relationship, Drug Motor Activity Weight Gain Drug Interactions Time Factors Brain Chemistry Sensory Gating Synaptic Transmission

Disciplines and Occupations5

Pharmacogenetics Pharmacoepidemiology Psychiatry Comparative Effectiveness Research Individualized Medicine

Anthropology, Education, Sociology and Social Phenomena1

United States Food and Drug Administration

Humanities2

Therapeutic Equipoise Scientific Misconduct

Information Science3

Pharmacovigilance Databases, Factual Adverse Drug Reaction Reporting Systems

Health Care27

Drug Substitution Pharmacovigilance Treatment Outcome Drug Costs Drug Utilization Analysis of Variance Nursing Homes Drug Prescriptions Drug Utilization Review Randomized Controlled Trials as Topic Physician's Practice Patterns Long-Term Care Medication Adherence Double-Blind Method Community Mental Health Centers Placebo Effect Homes for the Aged Comparative Effectiveness Research United States Food and Drug Administration Risk Factors Retrospective Studies Reimbursement Mechanisms Clinical Trials as Topic Hospitalization Comorbidity Cross-Sectional Studies Adverse Drug Reaction Reporting Systems

Geographicals3

Algeria Croatia United States

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Humanities Information Science Health Care Geographicals

Dopamine Antipsychotic Agents Receptors, Dopamine D2 Dopamine Antagonists Risperidone Receptors, Dopamine D1 Dopamine Agonists Clozapine Receptors, Dopamine Receptors, Dopamine D3 Haloperidol Dibenzothiazepines Schizophrenia Benzodiazepines Dopamine Plasma Membrane Transport Proteins Dopamine Agents Basal Ganglia Diseases Sulpiride Psychotic Disorders Receptors, Dopamine D5 Dopamine Uptake Inhibitors Corpus Striatum Dopamine beta-Hydroxylase Dyskinesia, Drug-Induced Apomorphine Psychotropic Drugs Catalepsy Off-Label Use Benzazepines Fluphenazine Schizophrenic Psychology Perphenazine Raclopride Pirenzepine Quinpirole Nucleus Accumbens Akathisia, Drug-Induced Piperazines Amphetamine Rats, Sprague-Dawley Receptor, Serotonin, 5-HT2A Polypharmacy Schizophrenia, Paranoid Microdialysis Chlorpromazine Psychomotor Agitation Startle Reaction Drug Substitution Phenothiazines Flupenthixol Pimozide Salicylamides Behavior, Animal Bipolar Disorder Cocaine Dose-Response Relationship, Drug Neostriatum Brief Psychiatric Rating Scale Levodopa Brain Psychiatric Status Rating Scales Dopaminergic Neurons Homovanillic Acid Thioridazine Remoxipride Antidepressive Agents Tyrosine 3-Monooxygenase Caudate Nucleus Quinolones Dopamine and cAMP-Regulated Phosphoprotein 32 Motor Activity Spiperone Hyperprolactinemia Weight Gain Substantia Nigra Ventral Tegmental Area Thiazoles Neurons Phencyclidine Serotonin Antagonists Oxidopamine Ergolines Pharmacovigilance Mesencephalon Mental Disorders Perazine Treatment Outcome Prefrontal Cortex Receptors, Serotonin Central Nervous System Stimulants Antimanic Agents Drug Interactions Serotonin Drug Costs Galactorrhea Pharmacogenetics Stereotyped Behavior Hyperkinesis Pharmacoepidemiology Antiparkinson Agents

No FAQ available that match "dopamine and antipsychotics"